Sinopharm Group
Chinese biotechnology company
Follow Sinopharm Group on Notably News to receive short updates to your email — rarely!
| 2021 | Sinopharm expected to produce one billion doses of the BIBP vaccine during the year, supporting global COVID-19 vaccination efforts. |
| May 7 2021 | World Health Organization (WHO) approved the Sinopharm BIBP COVID-19 vaccine for use in the COVAX global vaccination program. |
| December 2020 | UAE announced interim results showing 86% efficacy for the Sinopharm BIBP COVID-19 vaccine, demonstrating promising vaccine performance. |
This contents of the box above is based on material from the Wikipedia article Sinopharm Group, which is released under the Creative Commons Attribution-ShareAlike 4.0 International License.